These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20601803)

  • 1. Novel agents for the treatment of pancreatic adenocarcinoma: any light at the end of the tunnel? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Dimou AT; Syrigos KN; Saif MW
    JOP; 2010 Jul; 11(4):324-7. PubMed ID: 20601803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel agents for the treatment of pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Cheng H; Merika E; Syrigos KN; Saif MW
    JOP; 2011 Jul; 12(4):334-8. PubMed ID: 21737890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics and other molecular targets in the management of pancreatic adenocarcinoma. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Merika E; Syrigos KN; Saif MW
    JOP; 2010 Jul; 11(4):328-30. PubMed ID: 20601804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second line therapy for advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Brus C; Saif MW
    JOP; 2010 Jul; 11(4):321-3. PubMed ID: 20601802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel agents in the treatment of unresectable neuroendocrine tumors. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Oberstein PE; Saif MW
    JOP; 2011 Jul; 12(4):358-61. PubMed ID: 21737896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-line treatment of metastatic pancreatic adenocarcinoma: can we do better? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Merl MY; Abdelghany O; Li J; Saif MW
    JOP; 2010 Jul; 11(4):317-20. PubMed ID: 20601801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updates in locally advanced pancreatic cancer. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Chang BW; Siccion E; Saif MW
    JOP; 2010 Jul; 11(4):313-6. PubMed ID: 20601800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updates in pancreatic neuroendocrine carcinoma. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Alsamarai S; Libutti SK; Saif MW
    JOP; 2010 Jul; 11(4):336-40. PubMed ID: 20601807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant treatment for ampullary cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Kim R; Chabot J; Saif MW
    JOP; 2011 Jul; 12(4):362-3. PubMed ID: 21737897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updates on first-line treatment of metastatic pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Strimpakos AS; Syrigos KN; Saif MW
    JOP; 2011 Jul; 12(4):339-42. PubMed ID: 21737891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome of pancreatic cancer patients with diabetes mellitus: is diabetes a poor prognostic factor? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Kang SP; Saif MW
    JOP; 2010 Jul; 11(4):334-5. PubMed ID: 20601806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locally advanced pancreatic adenocarcinoma: are we making progress?. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Li J; Ng J; Allendorf J; Saif MW
    JOP; 2011 Jul; 12(4):347-50. PubMed ID: 21737893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers and pharmacogenetics in pancreatic cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Xu X; Strimpakos AS; Saif MW
    JOP; 2011 Jul; 12(4):325-9. PubMed ID: 21737888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes and pancreatic cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Hsu C; Saif MW
    JOP; 2011 Jul; 12(4):330-3. PubMed ID: 21737889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant Therapy of Pancreatic Cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Sharma C; Horowitz D; Chabot J; Saif MW
    JOP; 2011 Jul; 12(4):343-6. PubMed ID: 21737892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palliative care of pancreatic cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Saif MW
    JOP; 2011 Jul; 12(4):355-7. PubMed ID: 21737895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updates of adjuvant therapy in pancreatic cancer: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Li J; Merl MY; Chabot J; Saif MW
    JOP; 2010 Jul; 11(4):310-2. PubMed ID: 20601799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updates on treatment of gemcitabine-refractory pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Makrilia N; Syrigos KN; Saif MW
    JOP; 2011 Jul; 12(4):351-4. PubMed ID: 21737894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic cancer and thrombosis. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Shah MM; Saif MW
    JOP; 2010 Jul; 11(4):331-3. PubMed ID: 20601805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summary of presentations from the 46th annual meeting of the American Society Of Clinical Oncology (2010): focus on developmental therapeutics related to lung cancer.
    Morgensztern D; Pennell NA; Subramanian J; Govindan R
    Clin Lung Cancer; 2011 Mar; 12(2):94-9. PubMed ID: 21550555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.